Bruker BioSpin Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bruker BioSpin's estimated annual revenue is currently $212.3M per year.(i)
  • Bruker BioSpin's estimated revenue per employee is $155,000

Employee Data

  • Bruker BioSpin has 1370 Employees.(i)
  • Bruker BioSpin grew their employee count by 5% last year.

Bruker BioSpin's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VPReveal Email/Phone
3
Head Group FP&AReveal Email/Phone
4
Head Facility ManagementReveal Email/Phone
5
VP FinanceReveal Email/Phone
6
Head Solid state Probe head productionReveal Email/Phone
7
Head NMR ProductionReveal Email/Phone
8
Head Customer Data Management and Continuous ImprovementReveal Email/Phone
9
Head IT Project & Portfolio ManagementReveal Email/Phone
10
Head Applications Americas PCIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Bruker BioSpin?

The world’s most comprehensive range of magnetic resonance and preclinical imaging instrumentation available under one brand - a brand synonymous with excellence, innovation and quality. Bruker is offering a wide range of applications for molecular characterization in chemistry and life sciences as well as solutions for materials and preclinical research. The Bruker BioSpin business group includes NMR, EPR, compact and Time-Domain (TD) NMR, preclinical MRI, optical imaging, microCT, and PET/SPECT/CT.

keywords:N/A

N/A

Total Funding

1370

Number of Employees

$212.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bruker BioSpin News

2022-04-13 - Wine fraud in Spain could be ancient history with nuclear ...

Bruker Biospin is working with EEH to further grow the database of wines, running samples from Spain and France, Italy and Hungary to create...

2022-04-06 - Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies

Falko Busse, President of the Bruker BioSpin Group, commented: "The acquisition of Optimal is a very exciting step for Bruker as it supports...

2022-03-30 - NMR metabolic profiling on early identification and severity prediction of COVID-19*

Bruker BioSpin is continuing to revolutionize the design, manufacture and distribution of life science, preclinical, process control and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1040M35846%$129.5M
#2
$2360M48047%$22.5M
#3
$865.2M55827%N/A
#4
$2180M61493%N/A